Wits Health Consortium
Nozipho Mlotshwa is an experienced medical research technician currently working at Wits Health Consortium within the Wits/SAMRC Antiviral Gene Therapy Research Unit since November 2022. Previously, Nozipho held multiple roles at ICAP at Columbia University, including Viral Load Laboratory Technologist and Return of Results Coordinator, overseeing confidential biomarker test results and managing laboratory data systems. Earlier positions include Medical Laboratory Technologist and Laboratory Assistant at ICAP, as well as a Laboratory Analyst Intern at Montigny Investments. Nozipho has a solid educational background with a Bachelor’s Degree in Biotechnology from the University of Pretoria, achieved from 2013 to 2016.
This person is not in any teams
This person is not in any offices
Wits Health Consortium
10 followers
Wits Health Consortium (Pty) Limited (“WHC“) is a wholly owned Company of the University of the Witwatersrand, Johannesburg (South Africa) under its Faculty of Health Sciences. WHC provides Faculty with a legal framework within which to operate the research and other activities necessary to support its academic objectives. In addition WHC offers a range of products and services to the Academics conducting these activities in order to assist with the management thereof. WHC was formed in March 1998 to harness and stimulate the commercial potential within Faculty, and in particular to capitalise on clinical research. The flexible manner in which WHC is structured encourages academics to operate their entities along entrepreneurial lines with strong investigator ownership. WHC balances reducing unnecessary bureaucratic control whilst still ensuring that activities are conducted in a formalised, controlled and well managed environment. WHC has also been the fertile breeding ground for many initiatives, the most notable being the formation of the Wits Donald Gordon Medical Centre which was incubated within WHC and eventually established in its own entity. WHC is a not-for-profit organisation as all surpluses are reinvested in either WHC's or the University's operational and academic infrastructures.